Table 4 Selected recent biosensor studies based on CNTs
From: An Overview on Recent Progress of Metal Oxide/Graphene/CNTs-Based Nanobiosensors
Nanomaterials and morphology | Types of biosensors | LOD | Sensitivity | Lineer detection range | Analyte detected | Applications | References |
|---|---|---|---|---|---|---|---|
CNTs/Dendrimer-encapsulated Pt nanoclusters | Electrochemical Non-enzymatic | 0.8 µM | 987.5 µA mM−1 cm−2 | 0.003–0.4 mM | H2O2 | Clinical applications | Liu and Ding [144] |
CNTs/Pd-Co NPs | Electrochemical Non-enzymatic | 0.3 µM | – | 1 µM–1.11 mM | H2O2 | Clinical and nonclinical analysis | Huang et al. [145] |
1 µM | 75.4 µA mM−1 cm−2 | 10 µM–2.4 mM | Glucose | Diabetes | |||
CNTs/mucin composite | Electrochemical Amperometric | 3 μM | 0.44 ± 0.01 mA M−1 | 0.002–3.2 mM | Glucose | Diabetes | Comba et al. [146] |
MWCNTs/Graphene/Poly(diallyl dimethyl ammonium chloride) (PDADMAC) | Electrochemical | 4.40 μM | – | 5–50 μM | UA/Hypoxanthine | Clinical applications | Si et al. [147] |
CNTs/Co3O4/TiO2 | Photoelectrochemical | 0.16 μM | 0.3 μAmM − 1 cm − 2 | 0–4 mM | Glucose | Diabetes | Çakıroğlu and Özacar [148] |
CNTs/NiO/Poly(3,4-ethylenedioxythiophene) (PEDOT) | Electrochemical | 0.026 µM | 7.36 μA μM−1 cm−2 | 0.03–20 µM | DA | Clinical applications | Sun et al. [149] |
0.063 µM | 3.04 μA μM−1 cm−2 | 0.3–35 µM | Serotonin | ||||
0.210 µM | 0.92 μA μM−1 cm−2 | 1–41 µM | Tryptophan | ||||
CNTs/ZnFe2O4 | Colorimetric | 0.58 μM | – | 0.8–250 μM | Glucose | Diabetes | |
MWCNTs/GQDs/Au NPs/Chitosan | Electrochemiluminescence | 64 nM | – | 0.1–5000 μM | Glucose | Diabetes | |
MWCNTs/CdO NPs | Electrochemical | 4.0 pM | 25.7911 μA μM cm−2 | 0.01 nM–0.1 mM | M-tolyl hydrazine hydrochloride | Environmental safety | Rahman et al. [152] |
MWCNTs/PANI | Electrochemical | 10 µM | 0.38 μA mM−1 cm−2 | 10–50 µM | Urease | Disease diagnosis | Bao et al. [153] |
CNTs/ZnO NWs | Electrochemical Amperometric | 3.3 ng/µl | – | 3.3 ng/µl-3.3 mg/µl | Urine albumin | Medical applications | Tabatabaei et al. [154] |
MWCNTs/Fe3O4/PANI | Electrochemical Amperometric | 67 µM | – | 1.0–25.0 mM | Urease | Food analysis | Singh et al. [155] |
MWCNTs/AuNPs/PPy | Electrochemical Impedimetric | 0.1 × 10−3 M | 10.12 μA mM−1 cm−2 | 2 × 10−3–8 × 10−3 M | Cholesterol | Clinical applications | Alagappan et al. [156] |
MWCNTs/Ni(OH)2 | Electrochemical | 0.095 μmol L−1 | – | 0.5–26 μmol L−1 | Folic acid (vitamin B9) | Food safety | Winiarski et al. [157] |
Carboxylated SWCNTs/Molecularly imprinted polymer (MIP)/Chitosan | Electrochemical | 0.025 ng mL−1 | – | 0.04–7.6 ng mL−1 | Semicarbazide | Food safety | Yu et al. [158] |
MWCNTs/GQDs | Electrochemical | 0.87 nM | – | 0.005–100.0 μM | DA | Clinical applications | Huang et al. [159] |
MWCNTs/Co-based Metal organic framework (MOFs)/Au NPs | Electrochemical | 0.4 μM | 0.223 μA μM−1 | 1–1000 μM | Nitrite | Environmental safety | Lei et al. [160] |
SWCNTs | Electrochemical Field-effect transistor | 0.01 mM | 0.4–0.6 µA/mM | 0.01–2 mM | Glucose | Clinical and nonclinical applications | Pandey et al. [161] |
SWCNTs/Pt–Pd NiO NPs | Electrochemical | 3.0 nM | 0.2267 µA/µM | 0.008–350 µM | Daunorubicin | Clinical applications | Alizadeh et al. [162] |
0.1 µM | 0.5–330 µM | Tamoxifen | |||||
CNTs/Pt NPs/Au: Ru NPs | Electrochemical Amperometric | 0.068 mM | 0.2347 nA/(μM mm2) | 1 − 10 mM | Glucose | Prediabetes and diabetes | Nguyen et al. [163] |
MWCNTs/CoS NPs | Electrochemical | 5 μM | 15 mA M −1 cm−2 | 8 μM-1.5 mM | Glucose | Diabetes | Li et al. [164] |
CNTs/peptide-decorated Au NPs | Electrochemical | 6 pg/mL | – | 0.01–1000 ng/nL | Matrix metalloproteinase-7 | Cancer diagnosis | Palomar et al. [165] |
CNTs/Fe3O4 NPs/rGO | Electrochemical Amperometric | 0.54 μM | – | 1 − 50 μM | Antipsychotic drug trifluoperazine | Medical applications | Ognjanovic et al. [166] |